Charles Tsang

National University Cancer Institute, Singapore

Papers

1

Total Citations

255

H-Index

1

About

Charles Tsang is a leading figure in surgical oncology, with a primary focus on advancing minimally invasive techniques for colorectal cancer treatment. His most impactful work centers on the rigorous evaluation of robotic-assisted surgery versus standard laparoscopic approaches. In his landmark 2011 international, multicentre, prospective, randomised controlled trial—cited over 255 times—Tsang provided pivotal evidence on the safety, efficacy, and oncological outcomes of robotic surgery for rectal cancer. This study has shaped clinical guidelines and influenced surgical practice worldwide, establishing benchmarks for future comparative research. Beyond this trial, Tsang’s contributions extend to refining surgical protocols and improving patient recovery pathways, demonstrating a commitment to evidence-based innovation. His work is widely recognized for bridging the gap between emerging technology and practical surgical care, making him a key voice in the ongoing debate over the role of robotics in cancer surgery. For students and researchers, Tsang exemplifies how rigorous trial design can directly impact patient outcomes and drive the evolution of surgical standards.

Research Focus

Key Achievements

1
H-Index
1
Papers
255
Total Citations
255
Avg Citations/Paper
🏆 Most Cited Paper
An international, multicentre, prospective, randomised, controlled, unblinded, parallel-group trial of robotic-assisted versus standard laparoscopic surgery for the curative treatment of rectal cancer
255 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: National University Cancer Institute, Singapore

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago